WEBSTER™ Decapolar Catheter
WEBSTER™ Decapolar Catheter has been designed to facilitate electrophysiological mapping of cardiac structures. The catheter has a high-torque shaft with an array of platinum electrodes at the distal tip that can be used for stimulation and recording. Available in both fixed and deflectable platforms.
Related products
OCTARAY™ Mapping Catheter with TRUEref™ Technology
The OCTARAY™ Mapping Catheter with TRUEref™ Technology is designed to improve signal quality, enhance mapping speed, and unleash the full potential of the CARTO™ 3 System.
OPTRELL™ Mapping Catheter
To aid in the most complex cases, the OPTRELL™ Mapping Catheter’s intuitive design and fixed electrode array work with the CARTO™ 3 System to deliver intelligent insights and high-resolution directional mapping.
DECANAV™ Mapping Catheter
The DECANAV™ Catheter has been designed to be used with the CARTO™ 3 System to facilitate electrophysiological mapping of the heart.
The catheter has a single proximal electrode that can be used for unipolar recording signals. The catheter has a high-torque shaft with a deflectable tip section containing an array of platinum/iridium electrodes that can be used for stimulation and recording of cardiac electrical signals.
PENTARAY™ NAV ECO High Density Mapping Catheter
The PENTARAY™ NAV ECO High-Density Mapping Catheter is designed to facilitate electrophysiological mapping of the heart with the CARTO™ 3 System. This deflectable catheter consists of multiple 3 F spines on its distal tip, each spine having multiple platinum electrodes that are used for stimulation and recording.
References
DO NOT use OCTARAY™, PENTARAY™ NAV ECO High Density Mapping Catheters, or OPTRELL™ Mapping Catheters with TRUEref™ Technology in patients with prosthetic valves. For complete indications. contraindications, warnings, precautions and adverse reactions, please reference full package insert.
Always verify catheter tip location using common clinical practice for real-time verification (inspection of IC signals, direct imaging guidance such as fluoroscopy or ultrasound, etc.) and consult the CARTO™ 3 System User Guide regarding recommendations for fluoroscopy use. Canpolat, U. et al (2020). State of Fluoroless Procedures in Cardiac Electrophysiology Practice. J Innov Cardiac Rhythm Management. 11(3), 4018–4029. Sommer, P. et al (2018) Safety profile of near-zero fluoroscopy atrial fibrillation ablation with non-fluoroscopic catheter visualization: experience from 1000 consecutive procedures, EP Europace, Volume 20, Issue 12, Pages 1952–1958.
This site is published by Johnson & Johnson and its affiliates, which is solely responsible for its contents. It is intended for visitors from the United States. © Johnson & Johnson and its affiliates 2025 Last Updated on 10/16/2025.
US_ELP_DIAG_407975